
Tesamorelin / Ipamorelin 10MG / 3MG
No COA is linked to this product yet. Check the COA page or contact support if a document should be available.
Open COA pageSelect your amount and quantity.
Tesamorelin / Ipamorelin 10MG / 3MG Research Overview
This blend pairs TESA, a GHRH analog, with Ipamorelin, a selective ghrelin-receptor agonist, at 10 mg / 3 mg in a single vial for combined GH-axis research. Tesa / IPA 10MG / 3MG is supplied for qualified in-vitro laboratory research and analytical use only.
Compound profile
- Compound class: Two-peptide GH-axis research blend
- Components: TESA (GHRH analog) and Ipamorelin (ghrelin-receptor agonist)
- Amounts: 10 mg / 3 mg per vial
- Form: Lyophilized multi-peptide blend in a sealed vial
- Testing: Third-party HPLC purity and identity, batch-matched COA
Research context
GHRH-receptor and ghrelin-receptor signaling stimulate growth-hormone release through separate pathways that are studied for their combined, synergistic effect on GH pulses. The blend supports GH/IGF-axis models that examine both pathways together, with each component also available on its own as a control.
Storage and handling
Store unopened lyophilized vials sealed and protected from light — at −20 °C for long-term storage, or 2–8 °C for short-term use. Once reconstituted, keep refrigerated at 2–8 °C, minimize freeze–thaw cycles and rely on your laboratory’s own validated stability data.
Quality and documentation
Every lot is third-party tested, and the Certificate of Analysis is matched to the exact batch you receive — look it up any time on the COA page. Browse more GH / IGF Axis Research, or see related compounds: TESA, IPA 10MG.
Research Use Only Notice: Not for human consumption, not for veterinary use, not for clinical or diagnostic use, and not intended as a drug, food, dietary supplement, cosmetic, or household product. Purchaser is responsible for confirming lawful use, handling requirements, and regulatory status before purchase or use.